Storia in 9 fonti

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Indian pharma stocks are likely to remain in focus after US President Donald Trump announced a phased tariff plan for generic medicines, offering a two-year tariff exemption before imposing steep duties from 2028.

Raccontata da

timesofindia.indiatimes.com

economictimes.indiatimes.com

hindustantimes.com

thehindubusinessline.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.comStai leggendo7 h fa

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

originale

Timeline cronologica

mercoledì 22 luglio 2026·timesofindia.indiatimes.com
Trump announces 0% tariff on generic medicines for two years; 200% thereafter
US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…
mercoledì 22 luglio 2026·economictimes.indiatimes.com
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Confronto fonti

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Timeline cronologica

Trump announces 0% tariff on generic medicines for two years; 200% thereafter

Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Confronto fonti

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Timeline cronologica

Trump announces 0% tariff on generic medicines for two years; 200% thereafter

Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla…

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Trump threatens tariff on generic medicines: Should India be worried?

Trump announces 100% tariffs on imported generic pharmaceutical drugs

US to impose steep tariffs on generic medicine imports from Aug 2028

US to impose 100% tariffs on generic medicine imports from Aug 2028

Trump announces 100% tariffs on imported generic pharmaceutical drugs

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plan

Trump imposing 100pc tariff on generic drugs from August 2028

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

Trump threatens tariff on generic medicines: Should India be worried?

Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Pharma stocks decline; Aurobindo Pharma down over 4%

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Trump’s 100% generic drug duty threatens US low-cost supply

200% Trump tariff shock? India’s cheap pills may still beat US rivals

Indian pharma firms may yet survive Trump's 200% tariff bombshell

Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors